Health

Eli Lilly's Obesity Pill: A Viable Rival to Novo Nordisk's Wegovy

A closer look at the potential advantages of Eli Lilly's obesity pill, orforglipron, over its competitor Novo Nordisk's oral Wegovy.

• Read More